Patients with moderate and severe COVID-19 had increased plasma C5a levels, which could exert prothrombotic effects by upregulating PAI-1 and various tissue factors as well as by activating platelets15, 23, 37. This evidence concerns the gene SERPINE1 and COVID-19.